Themis Medicare informs about transcript of conference call

21 Nov 2022 Evaluate

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to its letter dated 7th November, 2022 intimating about the earning conference call for Q2 & H1 FY23 with Analysts/Investors held on 16th November, 2022, Themis Medicare has informed that it attached the transcript of the aforesaid conference call. The above information is also available on the website of the Company at https://www.themismedicare.com.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

105.60 -0.70 (-0.66%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×